Literature DB >> 8676464

In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue.

N Baumgarth1, A Kelso.   

Abstract

Influenza virus infection induces the local production of gamma interferon (IFN-gamma) by T cells and non-T cells in the respiratory tract. To elucidate the possible functions of this cytokine, the humoral and local cellular immune responses to influenza virus were studied in BALB/c mice with or without in vivo neutralization of IFN-gamma by using monoclonal antibodies. Neutralization of IFN-gamma led to a significant reduction in virus-specific titers of immunoglobulins G2a and G3 in serum but had little effect on other isotypes. Studies on cells isolated from the lung parenchyma itself revealed that at the height of the immune response the ability of these cells to produce cytokines after antigen or T-cell receptor/CD3 stimulation was not affected. Ex vivo cytolytic activity by lung parenchyma cells, which is induced by infection with this virus in normal mice, was also found to be undisturbed by this treatment, even though anti-IFN-gamma antibody activity was recovered from lung lavage samples and sera at all days studied. Surprisingly, in vivo neutralization of IFN-gamma led to a significant reduction in the magnitude of the cellular infiltrate in the lung tissue which followed infection, suggesting an involvement of IFN-gamma in the mechanisms that regulate increased leucocyte traffic in the inflamed lung parenchyma. This conclusion was supported by findings of differences between mock-treated and anti-IFN-gamma-treated mice in the number of CD8+ lung T cells expressing CD49d (alpha4-integrin) and CD62L at various times after influenza virus infection. This study therefore demonstrates that IFN-gamma affects the local cellular response in the respiratory tract as well as the systemic humoral response to influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676464      PMCID: PMC190374     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  The specificity of the high endothelial venule in bronchus-associated lymphoid tissue (BALT).

Authors:  G J van der Brugge-Gamelkoorn; G Kraal
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

2.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.

Authors:  G Karupiah; Q W Xie; R M Buller; C Nathan; C Duarte; J D MacMicking
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

3.  Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.

Authors:  J Stein-Streilein; M Bennett; D Mann; V Kumar
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

4.  ELECTROPHORETIC SEPARATION AND PROPERTIES OF MOUSE ANTIHAPTEN ANTIBODIES INVOLVED IN PASSIVE CUTANEOUS ANAPHYLAXIS AND PASSIVE HEMOLYSIS.

Authors:  R S NUSSENZWEIG; C MERRYMAN; B BENACERRAF
Journal:  J Exp Med       Date:  1964-08-01       Impact factor: 14.307

5.  Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.

Authors:  J S Pober; M A Gimbrone; R S Cotran; C S Reiss; S J Burakoff; W Fiers; K A Ault
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

6.  Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages.

Authors:  J C Unkeless; H N Eisen
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

7.  T cell regulation of IgG subclass antibody production in response to T-independent antigens.

Authors:  P K Mongini; K E Stein; W E Paul
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

8.  Response of resting human peripheral blood natural killer cells to interleukin 2.

Authors:  G Trinchieri; M Matsumoto-Kobayashi; S C Clark; J Seehra; L London; B Perussia
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

9.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

10.  Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia.

Authors:  S R Carding; W Allan; A McMickle; P C Doherty
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  49 in total

1.  The cytotoxic T-lymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon.

Authors:  X Y Mo; R A Tripp; M Y Sangster; P C Doherty
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Inflammatory impact of IFN-γ in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and -independent pathways.

Authors:  Chilakamarti V Ramana; Matthew P DeBerge; Aseem Kumar; Christopher S Alia; Joan E Durbin; Richard I Enelow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-23       Impact factor: 5.464

3.  Licensing delineates helper and effector NK cell subsets during viral infection.

Authors:  Anthony E Zamora; Ethan G Aguilar; Can M Sungur; Lam T Khuat; Cordelia Dunai; G Raymond Lochhead; Juan Du; Claire Pomeroy; Bruce R Blazar; Dan L Longo; Jeffrey M Venstrom; Nicole Baumgarth; William J Murphy
Journal:  JCI Insight       Date:  2017-05-18

4.  IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration.

Authors:  Lidia Yshii; Béatrice Pignolet; Emilie Mauré; Mandy Pierau; Monika Brunner-Weinzierl; Oliver Hartley; Jan Bauer; Roland Liblau
Journal:  JCI Insight       Date:  2019-04-04

5.  Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.

Authors:  Min-Chul Kim; Yu-Na Lee; Eun-Ju Ko; Jong Seok Lee; Young-Man Kwon; Hye Suk Hwang; Jae-Min Song; Byung-Min Song; Youn-Jeong Lee; Jun-Gu Choi; Hyun-Mi Kang; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang
Journal:  Mol Ther       Date:  2014-03-04       Impact factor: 11.454

Review 6.  Responses against complex antigens in various models of CD4 T-cell deficiency: surprises from an anti-CD4 antibody transgenic mouse.

Authors:  Yifan Zhan; Lorena E Brown; Georgia Deliyannis; Shirley Seah; Odilia L Wijburg; Jason Price; Richard A Strugnell; Phillip J O'Connell; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

7.  MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T-cell development upon influenza A virus infection.

Authors:  Katharina Köther; Carolin Nordhoff; Dörthe Masemann; Georg Varga; Jay H Bream; Matthias Gaestel; Viktor Wixler; Stephan Ludwig
Journal:  FASEB J       Date:  2014-06-16       Impact factor: 5.191

8.  CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination.

Authors:  Junbao Yang; Eddie James; Theresa J Gates; Jonathan H DeLong; Rebecca E LaFond; Uma Malhotra; William W Kwok
Journal:  Int Immunol       Date:  2013-03-22       Impact factor: 4.823

9.  B-cell fate decisions following influenza virus infection.

Authors:  Kristina Rothaeusler; Nicole Baumgarth
Journal:  Eur J Immunol       Date:  2010-02       Impact factor: 5.532

10.  Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae.

Authors:  Roongroje Thanawongnuwech; Brad Thacker; Patrick Halbur; Eileen L Thacker
Journal:  Clin Diagn Lab Immunol       Date:  2004-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.